1. Home
  2. RNTX vs AXIL Comparison

RNTX vs AXIL Comparison

Compare RNTX & AXIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RNTX

Rein Therapeutics Inc. Common Stock

BUY

Current Price

$1.55

Market Cap

38.9M

Sector

Health Care

ML Signal

BUY

Logo AXIL Brands Inc. Common Stock

AXIL

AXIL Brands Inc. Common Stock

HOLD

Current Price

$8.69

Market Cap

32.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNTX
AXIL
Founded
2001
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
38.9M
32.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RNTX
AXIL
Price
$1.55
$8.69
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
184.8K
1.5M
Earning Date
11-14-2025
01-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.15
Revenue
N/A
$27,262,468.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$54.81
Revenue Growth
N/A
0.07
52 Week Low
$1.04
$3.75
52 Week High
$3.50
$10.75

Technical Indicators

Market Signals
Indicator
RNTX
AXIL
Relative Strength Index (RSI) 58.01 81.91
Support Level $1.34 $4.93
Resistance Level $1.58 $9.86
Average True Range (ATR) 0.10 0.49
MACD 0.01 0.38
Stochastic Oscillator 87.50 77.28

Price Performance

Historical Comparison
RNTX
AXIL

About RNTX Rein Therapeutics Inc. Common Stock

Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03: a peptide for which company conducted a Phase 1b dose-ranging, placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis; LTI-01: proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment; and LTI-05 and others.

About AXIL AXIL Brands Inc. Common Stock

AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, and outdoor speakers, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering. The company operates two operating segments: hearing enhancement and protection, and hair and skin care.

Share on Social Networks: